BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.65B
AUM Growth
+$1.82B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$61.3M
2
+$34.9M
3
+$26.3M
4
IMVT icon
Immunovant
IMVT
+$21.7M
5
BCAX
Bicara Therapeutics
BCAX
+$21.2M

Top Sells

1
+$28M
2
+$8.36M
3
+$4.4M
4
ADAP
Adaptimmune Therapeutics
ADAP
+$2.28M
5
SAGE
Sage Therapeutics
SAGE
+$1.86M

Sector Composition

1 Healthcare 98.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$2.37B 24.59%
10,568,897
2
$2.03B 21.06%
30,739,020
+496
3
$659M 6.83%
42,877,916
4
$535M 5.54%
24,424,865
+1,202,643
5
$419M 4.34%
1,974,590
6
$343M 3.56%
7,569,090
7
$335M 3.47%
6,398,366
+1
8
$322M 3.34%
4,415,918
+839,880
9
$284M 2.94%
5,995,929
+1
10
$213M 2.2%
9,399,960
11
$156M 1.62%
5,840,059
12
$121M 1.25%
11,045,336
+1,000,000
13
$117M 1.21%
4,181,751
14
$109M 1.13%
3,731,695
15
$87.6M 0.91%
1,576,114
+109,567
16
$87.2M 0.9%
3,882,125
17
$77.8M 0.81%
4,865,819
18
$73.5M 0.76%
6,443,398
19
$71.6M 0.74%
27,525,640
20
$70.4M 0.73%
2,818,323
21
$67.7M 0.7%
4,092,310
+1,994
22
$60.7M 0.63%
111,904
23
$53.7M 0.56%
4,368,443
24
$47.2M 0.49%
1,515,318
25
$45.2M 0.47%
17,310,490
1
2 3 4